The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis

Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?

(2010) I. Nebie et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

A multifunctional serine protease primes the malaria parasite for red blood cell invasion

(2009) Konstantinos Koussis et al.   EMBO JOURNAL

The future for blood-stage vaccines against malaria

(2009) Jack S Richards et al.   IMMUNOLOGY AND CELL BIOLOGY

Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness

(2009) D. I. Stanisic et al.   INFECTION AND IMMUNITY

Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure

(2009) P. Bejon et al.   INFECTION AND IMMUNITY

A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings

(2009) Samuel Mabunda et al.   MALARIA JOURNAL

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

(2009) Bernhards R. Ogutu et al.   PLoS One

Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria

(2008) F. H. A. Osier et al.   INFECTION AND IMMUNITY

Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies

(2008) Kristina E.M. Persson et al.   JOURNAL OF CLINICAL INVESTIGATION

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

(2008) Daniel Dodoo et al.   MALARIA JOURNAL

Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults

(2008) Jinhong Hu et al.   PLoS One

Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum

(2008) Fiona J. McCallum et al.   PLoS One

A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria

(2008) Elissa Malkin et al.   VACCINE